Show simple item record

dc.contributor.authorMwanda, OW
dc.contributor.authorOrem, J
dc.contributor.authorFu, P
dc.contributor.authorBanura, C
dc.contributor.authorKakembo, J
dc.contributor.authorNess, A
dc.contributor.authorReynolds, S
dc.contributor.authorSubbiah, V
dc.contributor.authorBako, J
dc.contributor.authorJohnson, J
dc.contributor.authorKatongole-Mbidde, E
dc.contributor.authorRemick, SC
dc.date.accessioned2013-03-26T06:04:14Z
dc.date.issued2012
dc.identifier.citationDose-modified Oral Chemotherapy for AIDS-related non-Hodgkin’s Lymphoma in E.Aen
dc.identifier.urihttp://hdl.handle.net/11295/15048
dc.language.isoenen
dc.titleDose-modified Oral Chemotherapy for AIDS-related non-Hodgkin’s Lymphoma in E.Aen
dc.typePresentationen
local.embargo.terms6 monthsen
local.embargo.lift2013-09-22T06:04:14Z
local.publisherUniversity of Nairobi College of Health Sciencesen
local.publisherKenyatta National Hospital, Nairobien
local.publisherMakerere University School of Medicine and Uganda Cancer Institute, Kampalaen
local.publisherCase Western Reserve University School of Medicine and CASE CFAR & Comprehensive Cancer Center, Cleveland, Ohio, USAen
local.publisherMary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV, USA.en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record